Velasof – Sofosbuvir 400mg + Velpatasvir 100mg Hepatitis C Cure

Velasof (Sofosbuvir / Velpatasvir) (generic equivalent to Epclusa) is a prescription direct-acting antiviral (DAA) used to treat Chronic Hepatitis C Virus (HCV) infection. Modern DAA therapies like Velasof deliver cure rates exceeding 95% in most HCV genotypes.
Composition: Sofosbuvir (400mg) + Velpatasvir (100mg)
Treatment Course: Typically 8–12 weeks.
Manufacturer: Hetero Drugs Ltd
Prescription-only antiviral. Use under the supervision of a hepatologist or infectious disease specialist. Baseline genotyping and viral load testing required before starting treatment.